On February 10, 2022 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported that management will participate at these upcoming virtual investor conferences (Press release, Delcath Systems, FEB 10, 2022, View Source [SID1234608004]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 17, 2022, at 11:00 AM ET
This is a BTIG hosted event and will not be webcast. Please contact your BTIG representative for further information.

2022 SVB Leerink Global Healthcare Conference
February 18, 2022, at 9:20 AM ET
Webcast link: View Source
To learn more or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected].